MilliporeSigma, the life science business of Merck KgaA, Darmstadt, Germany, is an industry leader in the field of gene therapy with more than 30 years of experience and broad expertise across the entire workflow. We understand the unique pain points that innovators face, from optimizing upstream and downstream workflows to meeting accelerated manufacturing timelines and navigating new regulatory guidelines. We can proudly state that we were the first gene therapy CDMO to produce a commercial product following a successful regulatory inspection. Our global organization is ready to address your specific needs with an integrated, customizable offering.
Products